SCHEMBL348572

SCHEMBL348572

CC(C)(C)c1cc(CBr)cc(CBr)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.40
GABRB2 P47870 1/20 0.40
POLB P06746 1/20 0.37
HTR1D P28221 2/20 0.37
BCHE P06276 4/20 0.35
ACHE P22303 4/20 0.35
HMGCR P04035 2/20 0.35
CYP2C19 P33261 2/20 0.34
RXRA P19793 2/20 0.33
RXRB P28702 2/20 0.33
RXRG P48443 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
HIF1A Q16665 1/20 0.33
HTR1B P28222 1/20 0.33
TSHR P16473 3/20 0.32
ALDH1A1 P00352 2/20 0.32
TRPA1 O75762 1/20 0.32
HPGD P15428 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL478280 0.95 GABRA1 (0.46) GABRA1GABRB2POLBHTR1DBCHE
SCHEMBL4391448 0.86 TACR1 (0.43) GABRA1GABRB2POLBHTR1DHMGCR
SCHEMBL13208365 0.84 GABRA1 (0.33) GABRA1GABRB2POLBHTR1DHMGCR
SCHEMBL8826658 0.84 GABRA1 (0.33) GABRA1GABRB2POLBHTR1DHMGCR
SCHEMBL5352048 0.84 HMGCR (0.46) GABRA1GABRB2POLBHTR1DHMGCR
SCHEMBL29942298 0.84 HMGCR (0.46) GABRA1GABRB2POLBHTR1DHMGCR
SCHEMBL14508870 0.82 GABRA1 (0.33) GABRA1GABRB2BCHEACHEHMGCR
SCHEMBL29727697 0.81 RXRB (0.44) GABRA1GABRB2POLBHTR1DHMGCR
SCHEMBL5351634 0.78 ALDH1A1 (0.43) GABRA1GABRB2HMGCRRXRARXRB
SCHEMBL4726796 0.78 RXRA (0.46) ACHERXRARXRBRXRGALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12595251-B2 Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2026-04-07 US disclosed
EP-4603484-A2 COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS Georgia State University Research Foundation, Inc. (US) 2025-08-20 EP disclosed
CN-119837855-A Compounds for the treatment of bacterial infections and for the enhancement of antibiotics 乔治亚州大学研究基金会 2025-04-18 CN disclosed
US-20230105108-A1 COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2023-04-06 US disclosed
EP-4076420-A1 COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS Georgia State University Research Foundation, Inc. (US) 2022-10-26 EP disclosed
CN-114845708-A Compounds for treating bacterial infections and enhancing antibiotics 乔治亚州大学研究基金会 2022-08-02 CN disclosed
US-20210309641-A1 AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2021-10-07 US disclosed
WO-2021127452-A1 COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2021-06-24 WO disclosed
WO-2021127452-A1 COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2021-06-24 WO disclosed
EP-3806836-A1 AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS Georgia State University Research Foundation, Inc. (US) 2021-04-21 EP disclosed
US-20120016147-A1 METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-01-19 US disclosed
US-8048982-B2 Method for producing aromatic compound polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-11-01 US disclosed
EP-2241548-A1 Vanadium di-nuclear complex Sumitomo Chemical Company, Limited (JP) 2010-10-20 EP disclosed
EP-2241547-A1 Method for producing aromatic compound polymer Sumitomo Chemical Company, Limited (JP) 2010-10-20 EP disclosed
US-20090018309-A1 Method for Producing Aromatic Compound Polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-15 US disclosed
EP-1767560-A1 METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER Sumitomo Chemical Company, Limited (JP) 2007-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018309-A1 Method for Producing Aromatic Compound Polymer PAH, MAOA, AHR GABRA1 4385/4885GABRB2 4361/4885POLB 424/4885
US-20210309641-A1 AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS PAM, AMPD1, AMPD3 GABRA1 2670/4885GABRB2 2415/4885POLB 2742/4885
US-20230105108-A1 COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS BPGM, MYD88, PGLS GABRA1 1733/4885GABRB2 1043/4885POLB 342/4885
US-12595251-B2 Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics CLIC1, CBR3, CBR1 GABRA1 1123/4885GABRB2 1313/4885POLB 3463/4885
US-20120016147-A1 METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER PAH, MAOA, AHR GABRA1 4421/4885GABRB2 4371/4885POLB 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.